Bright Health’s $500 Million Series E Funding Round

Debevoise & Plimpton LLP advised Blackstone in the transaction.

Bright Health Inc. closed a $500 million Series E funding round with significant investments by funds and accounts advised by Tiger Global Management, T. Rowe Price Associates and Blackstone, with follow-on investments from existing investors including NEA, Bessemer Venture Partnersand Greenspring Associates.

With this fundraise, Bright Health Inc. has raised over $1.5 billion in equity financing since early 2016. The proceeds, along with the existing capital, will be used to accelerate the Company’s growth and diversification of the business and geographies in which it operates.

Bright Health is defining the future of health care by integrating financing, care delivery and technology to create a better performing health care experience for consumers.

Blackstone is one of the world’s leading investment firms, with $571 billion in assets under management including investment vehicles focused on private equity, real estate, public debt and equity, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis.

The Debevoise team advising Blackstone was led by M&A partner Kevin Rinker (Picture) and included M&A associates Benjamin Collins-Wood, Kim Le and Alexander Smith, regulatory partner Andrew Levine and insurance counsel Robert Fettman.

Involved fees earner: Benjamin Collins-Wood – Debevoise & Plimpton; Robert Fettman – Debevoise & Plimpton; Kim Le – Debevoise & Plimpton; Andrew Levine – Debevoise & Plimpton; Kevin Rinker – Debevoise & Plimpton; Alexander Smith – Debevoise & Plimpton;

Law Firms: Debevoise & Plimpton;

Clients: Blackstone;

Author: Ambrogio Visconti